SecBot SecBot
SECBOTREPLAY Home › Report › OTLK

OTLK · A significant insider buying cluster at Outlook Therapeutics, totaling…

Outlook Therapeutics, Inc. · CLUSTER filed Jun 3, 2026 at 18:03 ET

At the news

BULLISHIMPACT 7/10

CLUSTER filed Jun 3, 2026 at 18:03 ET

A significant insider buying cluster at Outlook Therapeutics, totaling $5.25M in open-market purchases, is dominated by a $5.0M purchase by Director and 10% Owner Ghiath M. Sukhtian. This buying occurred just days after the company completed a dilutive $4.9M offering and concurrently amended warrants, raising going-concern doubts. The cluster's size (4.6% of market cap) is highly material and suggests insiders see value despite the distressed capital structure.

  • Total insider purchases of $5.25M, representing ~4.6% of OTLK's $114M market cap.
  • Ghiath M. Sukhtian (Director, 10% Owner) purchased 8,539,709 shares at $0.5855 for $5.0M on May 28, 2026.
  • The purchase coincided with a $4.9M registered direct offering at $0.5855 per share, in which Sukhtian was the sole investor.
  • Other directors (Hilzinger, Thurman, Sukhtian Faisal, Haddadin) bought smaller amounts at prices between $0.41 and $0.83.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access